FRESENIUS KABI ONCOLOGY LTD Inactive Instrument
Company Fresenius Kabi Oncology Ltd
Equities
INE575G01010
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - INR | - |
|
| 2016 | AstraZeneca sells rights to anaesthetics for up to $770 million | RE |
| 2015 | Fresenius SE KGaA : Kabi sells German oncology compounding business | RE |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/18/01 | |
Rahul Sharma
DFI | Director of Finance/CFO | - | - |
Maria Gobbi
CHM | Chairman | - | 13/14/13 |
| Director/Board Member | - | 21/07/21 | |
| Director/Board Member | 63 | 11/08/11 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 11/08/11 | |
| Director/Board Member | - | 21/07/21 | |
Maria Gobbi
CHM | Chairman | - | 13/14/13 |
| Director/Board Member | - | 10/19/10 | |
| Chief Executive Officer | - | 01/18/01 | |
Maurizio Villa
BRD | Director/Board Member | - | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 480,427,326 | 0 | 0 | - |
Company contact information
Fresenius Kabi Oncology Ltd.
Echelon Institutional Area Plot No-11, Sector-32
122001, Gurgaon
+91 12 4488 5000
http://www.fresenius-kabi-oncology.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +9.83% | 12TCr | |
| +10.80% | 11TCr | |
| -10.84% | 2.34TCr | |
| -1.69% | 2.21TCr | |
| -10.23% | 1.83TCr | |
| -41.92% | 1.66TCr | |
| -15.11% | 1.6TCr | |
| +6.62% | 1.4TCr | |
| +17.53% | 1.17TCr |
- Stock Market
- Equities
- Stock
- Company Fresenius Kabi Oncology Ltd
